Ona Therapeutics
Edit

Ona Therapeutics

https://ona-therapeutics.com/
Last activity: 17.09.2026
Active
Categories: BioTechDevelopmentITResearchScienceWebsite
ONA Therapeutics is a biotech company, spin-off of ICREA and IRB, specializes in the discovery and development of therapeutic biologics targeting the lipid metabolism in order to treat advanced cancer.
Mentions
22
Location: Spain, Catalonia, Barcelona
Employees: 11-50
Total raised: $122.06M
Founded date: 2019

Investors 4

Funding Rounds 2

DateSeriesAmountInvestors
07.06.2026Series B$86.6M-
16.06.2020Series A$35.46M-

Mentions in press and media 22

DateTitleDescription
17.09.2026WuXi XDC Out-Licenses WuXiTecan-2 Payload-Linker Technology Platform to Ona Therapeutics to Advance Novel ADC Research and DevelopmentSHANGHAI, Sept. 17, 2026 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADC...
10.09.2026Spain's top-funded tech companies in H1 2026Spanish tech companies raised approximately €1.7 billion in H1 2026, with capital concentrated among a relatively small number of companies. The ten companies that raised the most accounted for around 68% of the total. Spacetech was the bes...
08.06.2026Europe's AI Revolution: Billions Fuel Tech Boom, Factorial Leads $2.5B ChargeEuropean tech is booming. Billions in capital flow weekly into innovative startups. AI innovation powers this massive surge. Workforce management giant Factorial just secured $150 million in Series D funding. Its valuation hit $2.5 billion....
08.06.2026European tech weekly recap: Over €2.3B invested in the tech ecosystem in the first week of JuneLast week, we tracked more than 55 tech funding deals worth over €2.3 billion and over 10 exits, M&A transactions, rumours, and related news stories across Europe. 📊 The top three industries that raised the most were analytics (€862.2 m...
07.06.2026Ona Therapeutics Raises $86.6 Million Series B To Advance First-In-Class ADC Cancer ProgramsOna Therapeutics, a biopharmaceutical company developing antibody-drug conjugates (ADCs) for treatment-resistant cancers, announced the close of an oversubscribed $86.6 million Series B financing to support the advancement of its oncology p...
04.06.2026Ona Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Development Ona Therapeutics Raises $86.6 Million Series B to Advance First-in-Class ADCs into Clinical Deve...Barcelona, Spain, 4 June 2026: Ona Therapeutics (“Ona”), a global biopharmaceutical company pioneering first-in-class antibody-drug conjugates (ADCs) to address treatment-resistant cancers, today announced the closing of an oversubscribed $...
04.06.2026Ona Therapeutics Raises $86.6M to Advance Cancer ADC PipelineFunding Supports Clinical Development Plans Ona Therapeutics has raised an $86.6 million oversubscribed Series B funding round that will finance the progression of its antibody-drug conjugate (ADC) pipeline in treatment-resistant cancers. T...
19.02.2025ONA Therapeutics Announces the Appointment of Dr Pamela Klein to its Board of Directors Ona Therapeutics Strengthens Leadership Team to Accelerate First-in-Class ADCs into Clinical Development Across ...• Dr. Aleix Prat, an internationally recognized leader in drug and biomarker development appointed Chair of the Advisory Board • Dr. Jutta Amersdorffer appointed as Chief Medical Officer and Stéphane Durant des Aulnois appointed as Chief Fi...
06.03.2024Which are Barcelona’s Most Influential Biotechnology Startups in 2023?Barcelona, the cosmopolitan capital of Spain’s Catalonia region, is famed not only for its art and architecture but also for its bustling biotechnology startup scene. Catalonian biotech startups have been turning heads globally thanks to th...
24.01.2024Who are Catalonia’s Most Influential Game-Changers in Biotech, 2023?The biotechnology scene in Catalonia, Spain, is thriving, with many innovative start-ups to its credit. Each of these companies is working towards the monumental task of pushing the boundaries of science to shape the future of healthcare, l...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In